Fluke Biomedical’s Model 74-001 IMRT phantom is designed to address commissioning and comparison of treatment planning systems and verification of individual patient plans and delivery.

Circular in shape, the phantom is approximately the size of an average patient, and is made from unique proprietary materials that reportedly mimic bone and water within 1 percent from 50 keV to 25 MeV, enabling thorough analysis of both the treatment planning and delivery systems.

The Isoloader from Core Oncology is an all-in-one physics workstation that automates brachytherapy needle loading, radioactive seed assay and reporting, and is optimized both for interoperative procedures and for streamlining preoperative preparation, assay, sterilization and loading.

The computer-based workstation has three primary functions:

- A dose calibrator that assays I-125 and Pd-103 radionuclide seeds and verifies that the measured strength is within a user-specified deviation from the strength ordered for the procedure.

Intrabeam is a miniature radiation source that delivers high dose, yet is a low energy X-ray used for breast cancer therapy, neurosurgery and other radiation therapies developed by Carl Zeiss Meditec.

The Intrabeam System can be used to treat early stage breast cancer. The radiation dose is administrated to the tumor bed in the operating room, following lumpectomy.

Accuray's InTempo Adaptive Imaging System enhances the CyberKnife Robotic Radiosurgery System’s ability to continually track and correct for motion of the prostate during treatment.

September 22, 2008—RapidMind, provider of the RapidMind Multi-core Development Platform, today launched the RapidMind Imaging Extensions, add-ons to the RapidMind platform that accelerate the development of applications such as those for medical imaging.

September 22, 2008 - Early aggressive treatment with chemotherapy prior to radiotherapy may prolong survival for patients with anaplastic oligodendrogliomas according to new research from the Radiation Therapy Oncology Group (RTOG) presented at ASTRO 2008.

RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

September 22, 2008 - Changes in gene expression during chemoradiation can predict the likelihood of response to therapy for women with locally advanced cervical cancer according to new research from the Radiation Therapy Oncology Group (RTOG) presented at ASTRO 2008.

RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

September 22, 2008 - Women with early stage breast cancer who choose lumpectomy and radiation as their treatment option may be able to significantly shorten their total treatment time using three-dimensional conformal radiation therapy (3DCRT) according to new research from the Radiation Therapy Oncology Group (RTOG) presented at ASTRO 2008.

RTOG, an NCI-funded national clinical trials group, is a clinical research component of the American College of Radiology (ACR).

September 22, 2008 – Siemens Healthcare is showcasing the Treago Robotic Table, designed for fast, precise patient positioning during radiation therapy, at ASTRO 2008.

The Treago is said to fully automate the entire positioning process, increasing accuracy, saving patient on-table time, and supporting complex treatment applications and provides clinicians the flexibility to personalize patient care.

September 22, 2008 - Using the Novalis Tx platform from Varian Medical Systems and BrainLAB, doctors are performing image-guided radiosurgery to treat tumors of the brain, spine, lung and liver, without a single incision in the patient.

This advanced technology is on display this week at ASTRO 2008 and at the Congress of Neurological Surgeons 2008 meeting in Orlando, FL.

Doctors are turning more and more to the use of stereotactic body radiosurgery (SBRT) for the treatment of cancer and other conditions.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now